Larvol Delta - The-novel-protein-homeostatic-modulator-BTX306-is-active-in-myeloma-and-overcomes-bortezomib-and-lenalidomide-resis-httpstcomtb4YmDZAA

Revlimid (lenalidomide) - BMS

bortezomib - Generic mfg.

BTX306 - BioTheryX

https://twitter.com/Myeloma_Doc/status/1281922016061394944

Jul 11, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev